NasdaqCM - Delayed Quote USD
Aspire Biopharma Holdings, Inc. (ASBPW)
0.0600
+0.0100
+(20.00%)
As of April 22 at 4:00:00 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Operating Expense
3,088.6710
3,088.6710
1,340.1680
596.4910
Operating Income
-3,088.6710
-3,088.6710
-1,340.1680
-596.4910
Net Non Operating Interest Income Expense
-342.9480
-342.9480
5,804.2470
--
Other Income Expense
-9,105.8530
-9,105.8530
--
--
Pretax Income
-12,537.4720
-12,537.4720
4,464.0790
-596.4910
Tax Provision
--
--
0.4810
0.6260
Net Income Common Stockholders
-12,537.4720
-12,537.4720
4,464.0790
-597.1170
Diluted NI Available to Com Stockholders
-12,537.4720
-12,537.4720
4,464.0790
-597.1170
Total Expenses
3,088.6710
3,088.6710
1,340.1680
596.4910
Net Income from Continuing & Discontinued Operation
-12,537.4720
-12,537.4720
4,464.0790
-597.1170
Normalized Income
-12,537.4720
-12,537.4720
4,464.0790
-597.1170
Interest Income
548.6760
548.6760
5,813.2130
--
Interest Expense
891.6240
891.6240
8.9660
--
Net Interest Income
-342.9480
-342.9480
5,804.2470
--
EBIT
-11,645.8480
-11,645.8480
4,473.0450
-596.4910
EBITDA
-11,645.8480
-11,645.8480
4,473.0450
-596.4910
Net Income from Continuing Operation Net Minority Interest
-12,537.4720
-12,537.4720
4,464.0790
-597.1170
Normalized EBITDA
-11,645.8480
-11,645.8480
4,473.0450
-596.4910
Tax Rate for Calcs
--
--
0.0002
0.0002
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
XRTX.V XORTX Therapeutics Inc.
1.5000
+4.17%
ANL Adlai Nortye Ltd.
2.0000
+9.29%
INTS Intensity Therapeutics, Inc.
1.3810
-23.58%
XBIO Xenetic Biosciences, Inc.
2.5550
+6.90%
NEUP Neuphoria Therapeutics Inc.
5.20
+2.97%
APRE Aprea Therapeutics, Inc.
1.5300
-0.65%
MBX MBX Biosciences, Inc.
8.98
+3.94%
BOLT Bolt Biotherapeutics, Inc.
0.3580
-0.83%
COCP Cocrystal Pharma, Inc.
1.3635
-2.61%
GLYC GlycoMimetics, Inc.
0.2522
+10.61%